Lymphoblastic Lymphoma — Trials

Lymphoblastic Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

263 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 58
Recruiting: 35
Ph III recruiting: 2
Growth YoY: —
Industry share: 10%
Top sponsor: City of Hope Medical Center
Termination share: 37%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (47)

clinicaltrialsPublishedShowing 1–31 of 31 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06514794	A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)	recruiting	Phase 2	125	Allotera TherapeuticsINDUSTRY	2	Sep 28, 2026	clinicaltrials
NCT03779854	Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant	active not recruiting	Phase 2	45	Fred Hutchinson Cancer CenterOTHER	1	Sep 25, 2026